Trials / Unknown
UnknownNCT03975374
To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension
Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 5,000 (estimated)
- Sponsor
- Sutphin Drugs · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to compare and describe efficacy and safety of Tobradex ophthalmic suspension versus generic Tobramycin/dexamethasone Suspension in treatment of Blepharoconjuctivitis through clinical parameters
Detailed description
Evaluation of signs and symptoms during treatment, with a record of individual scores for each parameter; Observation and statistical comparison of drug safety, by recording qualitative and quantitative parameters related to adverse effects occurring during treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tobramycin/dexamethasone opthalmic solution | To compare efficacy and safety in randomized patients recieving Tobradex versus Tobramycin/Dexamethasone opthamic Solution |
| DRUG | Tobradex Opthalmic Solution | Tobradex Opthalmic Solution |
Timeline
- Start date
- 2019-06-15
- Primary completion
- 2019-07-01
- Completion
- 2020-06-30
- First posted
- 2019-06-05
- Last updated
- 2019-06-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03975374. Inclusion in this directory is not an endorsement.